Clinical Focus

  • Hematology
  • Hematology/Oncology

Academic Appointments

Honors & Awards

  • KL2 Fellowship, Spectrum (2014-2016)
  • Young Investigator Award, ASCO (2014)

Stanford Advisors

Current Research and Scholarly Interests

My primary research interest is in improving outcomes in acute myeloid leukemia (AML). From a clinical trial standpoint, I am interested in combining novel small molecule inhibitors with conventional chemotherapy. From a population-based standpoint, I am conducting a retrospective analysis of outcomes in AML patients at Stanford who have undergone hematopoietic cell transplantation, as well as a collaborative project with the Cancer Prevention Institute of California analyzing outcomes in AML patients with data from the Surveillance and Epidemiology End Results (SEER).